Adventures in pharmacology, aspirin, prostacyclin and nitric oxide

Acta Cardiologica

Volumn 59, Issue SUPPL. 1, 2004, Pages 47-50

  Moncada, Salvador ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIUM DERIVED RELAXING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN;

CONFERENCE PAPER; DRUG MECHANISM; HISTORY OF MEDICINE; NON PROFIT ORGANIZATION; PHARMACOLOGY; THROMBOCYTE METABOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; EPOPROSTENOL; HUMANS; NITRIC OXIDE; PLATELET AGGREGATION INHIBITORS;

EID: 2942735383     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.59.1.2005158     Document Type: Conference Paper

References (37)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232-5.
2. Smith JH, Willis AL. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971; 231: 235-7.
3. Ferreira SH, Moncada S, Vane JR. Indomethacin and aspirin abolish prostaglandin release from spleen. Nature 1971; 231: 237-9.
4. Moncada S, Ferreira SH, Vane JR. Pain and inflammatory mediators. In Ferreira SH and Vane JR, eds. Handbook of Experimental Pharmacology, Springer Verlag, Berlin, Heidelberg, New York, 1978, Vol. 50, pp. 588-616.
5. Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci USA, 1975; 72: 2994-8.
6. 2 from prostaglandin endoperoxides. Nature (Lond.) 1976; 261: 558-60.
7. Moncada S, Gryglewski RJ, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (Lond.) 1976; 263: 663-5.
8. Patrono C. Aspirin and human platelets: from clinical trials to acetylation of cyclo-oxygenase and back. Trends Pharmacol Sci 1989; 10: 453-8.
9. Antiplatelet Trialists' Collaboration. Br Med J 1994; 308: 159-68.
10. International Stroke Trial Collaborative Group. The International Stroke Trial: a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
11. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94: 252-266.
12. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 1975; 72: 3073-6.
13. Vane JR, Botting RM. The history of anti-inflammatory drugs and their mechanism of action. In Bazan N, Botting J and Vane JR, eds. New targets in inflammation: inhibitors of COX-2 or adhesion molecules. Kluwer Academic Publishers, The Netherlands, 1996, pp. 1-12.
14. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
15. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 1984; 24: 175-97.
16. Moncada S, Palmer RMJ, Higgs EA. Prostacyclin and endothelium-derived relaxing factor: biological interactions and significance. In Verstraete M, Vermylen J, Lijnen HR and Arnout J, eds. Thrombosis and Haemostasis, Leuven University Press, 1987, pp. 597-618.
17. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
18. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
19. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews 1991; 4: 109-42.
20. Moncada S, Higgs EA. The L-arginine:nitric oxide pathway. N Engl J Med 1993; 329: 2002-12.
21. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60-7.
22. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992; 266: 68-71.
23. Gillespie JS, Liu X, Martin W. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system. In Moncada S and Higgs EA, eds. Nitric oxide from L-arginine: a bioregulatory system, Elsevier Science Publishers B.V., Amsterdam, 1990, pp. 147-64.
24. Rand MJ. Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol 1992; 19: 147-69.
25. Toda N. Nitric oxide and the regulation of cerebral arterial tone. In Vincent S, ed. Nitric oxide in the nervous system, Academic Press Ltd., Orlando, 1995, pp. 207-25.
26. Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
27. Nussler AK, Billiar TR. Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukoc Biol 1993; 54: 171-8.
28. Vallance P, Moncada S. The role of endogenous nitric oxide in septic shock. New Horizons 1993; 1: 77-86.
29. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases. FEBS Lett 1994; 345: 50-4.
30. Brown GC, Cooper C. Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett, 1994; 356: 295-8.
31. Schweizer M, Richter C. NO potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 1994; 204: 169-75.
32. Clementi E, Brown GC, Foxwell N, Moncada S. On the mechanism by which vascular endothelial cells regulate their oxygen consumption. Proc Natl Acad Sci USA, 1999; 96: 1559-62.
33. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci USA 1998; 13: 7631-6.
34. Beltran B, Mathur A, Duchen MR, Erusalimksy JD, Moncada S. The effect of nitric oxide synthase activation triggered apoptosis in primary cortical neurons. J Neurochem 2001; 77: 676-90.
35. Almeida A, Almeida J, Bolanos JP, Moncada S. Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically-generated ATP in astrocyte protection. Proc Natl Acad Sci USA, 2001; 98: 15294-9.
36. Beltrán B, Quintero M, Garcia-Zaragozá, O'Connor E, Esplugues JV, Moncada S. Inhibition of mitochondrial respiration by endogenous nitric oxide: a critical step in Fas signalling. Proc Natl Acad Sci USA 2002; 99: 8892-7.
37. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-30.